ProPhase Labs, Inc. Sale of Stock, Price Per Share
ProPhase Labs, Inc. (PRPH) had Sale of Stock, Price Per Share of $0.09 per share as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockPricePerShare · last filed 2026-08-19
- 2026-06-30: Sale of Stock, Price Per Share $0.09.
- 2026-03-31: Sale of Stock, Price Per Share $0.09.
- 2025-12-31: Sale of Stock, Price Per Share $0.45.
- 2024-12-31: Sale of Stock, Price Per Share $7.57; Sale of Stock, Price Per Share as first filed $0.76.
| Period end | Sale of Stock, Price Per Share | Sale of Stock, Price Per Share as first filed |
|---|---|---|
| 2026-06-30 | $0.09 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $0.09 10-Q/A · filed 2026-07-09 | |
| 2025-12-31 | $0.45 10-K · filed 2026-06-01 | |
| 2024-12-31 | $7.57 10-K · filed 2026-06-01 | $0.76 10-K · filed 2025-04-01 |
| 2023-12-31 | $4.52 10-K · filed 2025-04-01 | |
| 2023-09-30 | $4.37 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $7.26 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $7.62 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $9.63 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |